Erratum: Stage-stratified analysis of prognostic significance of tumor size in patients with gastric cancer (PLoS ONE (2013) 8, 1 (e54502) DOI: 10.1371/journal.pone.0054502);Stage-Stratified Analysis of Prognostic Significance of Tumor Size in Patients with Gastric Cancer

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Zu, Hongliang ^a   Wang, Feng ^a   Ma, Yan ^a   Xue, Yingwei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; TISSUE CHARACTERIZATION; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84873849453     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109497     Document Type: Erratum

References (27)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
3. Smith DD, Schwarz RR, Schwarz RE, (2005) Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: Data from a large US-population database. J Clin Oncol 23: 7114-7124.
4. Siewert JR, Botcher K, Stein HJ, Roder JD, (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449-61.
5. Hohenberger P, Gretschel S, (2003) Gastric cancer. Lancet 362: 305-15.
6. Dicken BJ, Bigam DL, Cass C, Mackey JR, JoyAA, et al, (2005) Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 241: 27-39.
7. Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K, et al. (1997) Tumor size as asimple prognostic indicator for gastric carcinoma. Ann Surg Oncol 4: 137-140.
8. Giuliani A, Caporale A, DiBari M, Demoro M, Gozzo P, et al. (2003) Maximum gastric cancer diameter as a prognostic indicator: Univariate and multivariate analysis. J Exp Clin Cancer Res 22: 531-538.
9. Yokota T, Ishiyama S, Saito T, Teshima S, Narushima Y, et al. (2004) Lymph node metastasis as significant prognostic factor in gastric cancer: A multiple logistic regression analysis. Scand J Gastroenterol 39: 380-384.
10. Yokota T, Ishiyama S, Saito T, Teshima S, Yamada Y, et al. (2002) Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res 22: 3673-3677.
11. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, et al. (2006) Macroscopic tumor size as a simple prognostic indicator inpatients with gastric cancer. Am J Surg 192: 296-300.
12. Liu X, Xu Y, Zh H, Wang Y, (2009) Prognostic Significance of Tumor Size in T3 Gastric Cancer. Ann Surg Oncol 16: 1875-1882.
13. Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, et al. (2004) Clinicopathological characteristics of patients with proximal third gastric carcinoma Acta Chir. Belg104: 667-682.
14. Zhang M, Zhu GY, Zhang HF, Gao HY, Han XF, et al. (2010) Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma. J Surg Oncol 102: 64-67.
15. Kitamura K, Beppu R, Anai H, Ikejiri K, Yakabe S, et al. (1995) Clinicopathologic study of patients with Borrmann type IV gastric carcinoma. J Surg Oncol 58: 112-7.
16. Maehara Y, Moriguchi S, Orita H, Kakeji Y, Haraguchi M, et al. (1992) Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric section. Surg Gynecol Obstet 175: 13-6.
17. Wang X, Wan F, Pan J, Yu GZ, Chen Y, et al. (2008) Tumor Size: A Non-Neglectable Independent Prognostic Factor for Gastric Cancer. J Surg Oncol 97: 236-240.
18. Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, et al. (1992) Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer 70: 392-5.
19. Wu CW, Hsieh MJ, Lo SS, Tsay SH, Lui WY, et al. (1994) Lymph node metastasis from carcinoma of the distal one-third of the stomach. Cancer 73: 2059-64.
20. Kikuchi S, Katada N, Sakuramoto S, Kobayashi N, Ahimao H, et al. (2004) Survival after surgical treatment of early gastric cancer: surgical techniques and long term survival. Langenbecks Arch Surg 389: 69-74.
21. Li C, Oh SJ, Kim S, Hyung WJ, Yan M, et al. (2009) Risk Factors of Survival and Surgical Treatment for Advanced Gastric Cancer with Large Tumor Size. J Gastrointest Surg 13: 881-885.
22. Kim DY, Joo JK, Park YK, Ryu SY, et al. (2007) Predictors of long-term survival in node-positive gastric carcinoma patients with curative resection. Langenbecks Arch Surg 392: 131-134.
23. Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, et al. (1997) Surgical treatment and outcome for node-negative gastric cancer. Surgery 121: 633-639.
24. Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, et al. (2010) Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol 101: 622-625.
25. Kim DY, Seo KW, Joo JK, Park YK, Ryu SY, et al. (2006) Prognostic factors in patients with node-negative gastric carcinoma: A comparison with node-positive gastric carcinoma. World J Gastroenterol 12: 1182-1186.
26. Kikuchi Y, Tsuchiya A, Ando Y, Yoshida T, Takenosita S, (1999) Immunohistochemical detection of lymph node microinvolvement in node-negative. Gstric Cancer 2: 173-178.
27. Aoyama T, Yoshikawa T, Watanabe T, Hayashi T, Ogata T, et al. (2011) Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1. Gastric Cancer 14: 274-278.